Ablation of Left Atrial Tachycardia following Catheter Ablation of Atrial Fibrillation: 12-Month Success Rates

作者
Armin Luik,Kerstin Schmidt,Annika Haas,Laura Unger,Panagiotis Tzamalis,Bernd Brüggenjürgen
出处
期刊:Journal of Clinical Medicine [Multidisciplinary Digital Publishing Institute]
卷期号:11 (4): 1047-1047 被引量:9
标识
DOI:10.3390/jcm11041047
摘要

The treatment of atrial tachycardia following catheter ablation of atrial fibrillation is often challenging. Electrophysiological studies using high-resolution 3D mapping systems have contributed significantly to their understanding, and new ablation approaches have shown high rates of acute terminations with low recurrences for the clinical AT. However, patient populations are very heterogeneous, and long-term data of the freedom from any atrial tachycardia or any arrhythmia are still sparse. To evaluate long-term success, a unified patient population and predefined ablation strategies are preferred. In this study, we present 12-month success and mean 30 month follow-up data of catheter ablation of left atrial tachycardia. All 35 patients had a history of pulmonary vein isolation (PVI), 71% of which had a previous substrate modification. A total of 54 ATs, with a mean cycle length 297 ± 86 ms, 31 macro-reentries, and 4 localized reentries, were targeted. The ablation strategy to be used was given by the study protocol, depending on the type of reentry and the number of critical isthmuses. All available ablation strategies were included: standard (anatomical) lines, individual lines, critical isthmuses, and focal ablation. All ATs were terminated by ablation. A total of 91% terminated upon the first ablation strategy. Freedom from any AT after 12 months was 82%, and from any arrhythmia, it was 77%. The multi-procedure success after 30 months was 65% for any AT and 55% for any arrhythmia. In conclusion, individual ablation strategies based on the reentry mechanism and the number of critical isthmuses seems promising and demonstrates a high long-term clinical success. Tachycardia comprising a single critical isthmus can be ablated by critical isthmus ablation only. These patients present with the highest 12-month and long-term success rates.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
可宝想当富婆完成签到,获得积分10
刚刚
刚刚
1秒前
1121发布了新的文献求助10
2秒前
2秒前
2秒前
魁梧的怜南应助藤井树采纳,获得10
2秒前
斯文败类应助yyt采纳,获得10
2秒前
月亮发布了新的文献求助10
2秒前
3秒前
JamesPei应助吴雨茜采纳,获得10
3秒前
3秒前
seeding发布了新的文献求助30
3秒前
12345678发布了新的文献求助10
4秒前
彭于晏应助1234采纳,获得10
4秒前
cdercder应助Anna采纳,获得30
4秒前
Kakaluote发布了新的文献求助10
5秒前
顺利毕业呀完成签到,获得积分10
5秒前
datang完成签到,获得积分10
5秒前
6秒前
殷超发布了新的文献求助10
6秒前
Lighters完成签到 ,获得积分10
8秒前
8秒前
llll发布了新的文献求助10
8秒前
shane发布了新的文献求助10
8秒前
horb完成签到,获得积分10
8秒前
333完成签到,获得积分10
9秒前
9秒前
byyyy发布了新的文献求助10
9秒前
9秒前
昨夜星辰完成签到,获得积分10
10秒前
10秒前
12345678完成签到,获得积分10
11秒前
11秒前
11秒前
逺山長发布了新的文献求助30
12秒前
12秒前
12秒前
Tao17完成签到,获得积分10
13秒前
叶坊发布了新的文献求助10
13秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Direct and Iterative Linear System Solvers 500
Plato's Parmenides. A Constructive Reading 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7302103
求助须知:如何正确求助?哪些是违规求助? 8920274
关于积分的说明 18894352
捐赠科研通 6966265
什么是DOI,文献DOI怎么找? 3211512
关于科研通互助平台的介绍 2380523
邀请新用户注册赠送积分活动 2188514